Chimera Investment (CIM)
(Delayed Data from NYSE)
$11.90 USD
+0.12 (1.02%)
Updated May 31, 2024 04:00 PM ET
After-Market: $11.90 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
C Value F Growth A Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.90 USD
+0.12 (1.02%)
Updated May 31, 2024 04:00 PM ET
After-Market: $11.90 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
C Value F Growth A Momentum F VGM
Zacks News
Earnings Preview: Chimera Investment (CIM) Q4 Earnings Expected to Decline
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AGNC Investment's (AGNC) Q4 Earnings Beat Estimates, NII Up
by Zacks Equity Research
AGNC Investment's (AGNC) Q4 earnings reflect growth in comprehensive income per common share and net interest income.
Chimera Investment (CIM) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -1.96% and -0.64%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AGNC Investment (AGNC) Q2 Earnings Lag Estimates, NII Slips
by Zacks Equity Research
AGNC Investment's (AGNC) Q2 earnings indicate a decline in net interest income. Further, the company's tangible net book value per share witnesses a year-over-year decline.
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chimera (CIM) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Given the recovery in the agency MBS sector, Chimera Investment (CIM) will likely reap benefits of higher exposure to this investment vehicle in Q1.
AGNC Investment's (AGNC) Q1 Earnings Miss, Dividend Cut
by Zacks Equity Research
AGNC Investment (AGNC) first-quarter 2019 earnings indicate a decline in net interest income. Further, the company suggests a decline in its monthly dividends.
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Hold AGNC Investment Stock in Your Portfolio Now?
by Zacks Equity Research
AGNC Investment (AGNC) is making efforts to reposition its portfolio in order to hedge interest rate risks. However, volatile market and choppiness in global economic environment remain concerns.
Chimera Investment (CIM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Chimera Investment (CIM) closed at $18.90, marking a +0.05% move from the previous day.
Top Ranked Income Stocks to Buy for April 8th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 8th:
What Makes Chimera (CIM) a New Strong Buy Stock
by Zacks Equity Research
Chimera (CIM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for March 29th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Is Chimera Investment (CIM) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (CIM) Outperforming Other Finance Stocks This Year?
Top Ranked Income Stocks to Buy for March 28th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 27th.
Top Ranked Income Stocks to Buy for March 27th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 27th.
Top Ranked Income Stocks to Buy for March 25th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 25th.
Two Harbors (TWO) Issues Public Offering of 18M Common Stock
by Zacks Equity Research
Two Harbors Investment (TWO) commences public offering of 18 million shares of common stock, proceeds of which will be used for targeted asset acquisitions.
Top Ranked Income Stocks to Buy for March 15th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 15th:
Top Ranked Income Stocks to Buy for March 14th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 14th:
Top Ranked Income Stocks to Buy for March 12th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 12th:
Top Ranked Income Stocks to Buy for March 8th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 8th
Chimera (CIM) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Chimera (CIM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Top Ranked Income Stocks to Buy for February 15th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, February 15th